Labcorp extends receivables purchase agreement to Jan 2029, adds $125M accordion facility

LABCORP HOLDINGS INC.

Termination date extended to January 26, 2029.
New $125M accordion allows facility increase from $700M up to $825M, exercisable until May 29, 2026.
0.10% SOFR adjustment removed from yield calculation on daily 1M SOFR or term SOFR rate.
Off-balance sheet vehicle Labcorp Receivables LLC is a separate legal entity; its assets not available to parent creditors.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

LABCORP HOLDINGS INC. amended Receivables Purchase Agreement with PNC Bank, National Association valued at $125 million accordion facility (effective 2026-01-28).

Action: amendment
Agreement: credit facility
Counterparty: PNC Bank, National Association
Value: $125 million accordion facility
Effective: 2026-01-28

Exact text from the filing

On January 28, 2026, Labcorp Holdings Inc. (the “Company”) amended its receivables purchase agreement (as amended, the “Receivables Purchase Agreement”) by entering into the Second Amendment to the Receivables Purchase Agreement (the “RPA Amendment”), among Labcorp Receivables LLC (“Labcorp Receivables”), Laboratory Corporation of America Holdings, PNC Bank, National Association, as administrative agent and the other parties thereto and acknowledged and agreed by the Company.

View on SEC.gov

314 material agreements filed in the last 30 days. Browse all material agreements →

LABCORP HOLDINGS INC. filing history →

Source: SEC EDGAR

accession 0000920148-26-000017

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.